Intra-Nasal Mechanical Stimulation (INMEST) as a Treatment of Keratoconjunctivitis Sicca (Dry Eye Syndrome)
NCT ID: NCT03418259
Last Updated: 2022-12-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2018-02-12
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active KCS Medical Device
KCS Medical Device
Patient treated 6 times with the Active KCS Medical Device during 2 weeks.
Inactive KCS Medical Device
KCS Medical Device
Patient treated 6 times with the Inactive KCS Medical Device during 2 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
KCS Medical Device
Patient treated 6 times with the Active KCS Medical Device during 2 weeks.
KCS Medical Device
Patient treated 6 times with the Inactive KCS Medical Device during 2 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non-invasive breakup time, NIBUT \< 11 seconds.
Exclusion Criteria
* Non-invasive breakup time, NIBUT \> 11 seconds.
20 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Källmark Clinic
OTHER
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jan-Erik Juto
Principal Investigator, M.D., Ph.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan-Erik Juto, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Clinical Science, Intervention and Technology (CLINTEC), H9, Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Källmarkskliniken
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INMESTfordryeyes2018
Identifier Type: -
Identifier Source: org_study_id